StockClub

ARWR

ARWRArrowhead Pharmaceuticals, Inc.$ --
Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

ARWR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q1
Revenue
264M USD
YoY +10461.3%
Operating Income
41M USD
YoY +125.3%
Net Income
31M USD
YoY +117.8%
EPS
0.22$
YoY +115.8%

Revenue

$264M
FY2024 Q2$3.6M
$3.6M
Q2
FY2024 Q3$3.6M
$3.6M
Q3
FY2024 Q4$27.1M
$27.1M
Q4
FY2025 Q1$2.5M
$2.5M
Q1
FY2025 Q2$545.2M
$545.2M
Q2
FY2025 Q3$573M
$573M
Q3
FY2025 Q4$829.4M
$829.4M
Q4
FY2026 Q1$264M
$264M
Q1
Actual
+$261.5M (+10461.3%)

Net Income

$30.8M
FY2024 Q2$-258.2M
$-258.2M
Q2
FY2024 Q3$-429M
$-429M
Q3
FY2024 Q4$-599.5M
$-599.5M
Q4
FY2025 Q1$-173.1M
$-173.1M
Q1
FY2025 Q2$197.4M
$197.4M
Q2
FY2025 Q3$22.1M
$22.1M
Q3
FY2025 Q4$-1.6M
$-1.6M
Q4
FY2026 Q1$30.8M
$30.8M
Q1
Actual
+$203.9M (+117.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$88M
Est:$132.1M
FY2020MISS
$88M
FY2021BEAT
Actual:$138.3M
Est:$134.6M
FY2021BEAT
$138.3M
FY2022MISS
Actual:$243.2M
Est:$255.6M
FY2022MISS
$243.2M
FY2023BEAT
Actual:$240.7M
Est:$35.5M
FY2023BEAT
$240.7M
FY2024MISS
Actual:$3.6M
Est:$62.1M
FY2024MISS
$3.6M
FY2025BEAT
Actual:$829.4M
Est:$764.6M
FY2025BEAT
$829.4M

Analyst Estimates